0.232EUR
59.32 MEUR
6.59 BEUR
291.30 M
About GRIFOLS S.A.
Sector
CEO
Nacho Abia
Headquarters
Barcelona
Website
Employees (FY)
23.74 K
Founded
1940
ISIN
ES0171996087
FIGI
BBG000KXQMX1
Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GRF is 8.602 EUR — it has increased by 4.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange GRIFOLS S.A. stocks are traded under the ticker GRF.
GRIFOLS S.A. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
GRF stock is 6.89% volatile and has beta coefficient of 1.47. Check out the list of the most volatile stocks — is GRIFOLS S.A. there?
GRF earnings for the last quarter are 0.14 EUR per share, whereas the estimation was 0.19 EUR resulting in a −26.11% surprise. The estimated earnings for the next quarter are 0.20 EUR per share. See more details about GRIFOLS S.A. earnings.
GRIFOLS S.A. revenue for the last quarter amounts to 1.49 B EUR despite the estimated figure of 1.59 B EUR. In the next quarter revenue is expected to reach 1.77 B EUR.
Yes, you can track GRIFOLS S.A. financials in yearly and quarterly reports right on TradingView.
GRF stock has risen by 1.44% compared to the previous week, the month change is a 1.58% fall, over the last year GRIFOLS S.A. has showed a 8.92% decrease.
GRF net income for the last quarter is 55.99 M EUR, while the quarter before that showed 59.54 M EUR of net income which accounts for −5.96% change. Track more GRIFOLS S.A. financial stats to get the full picture.
Today GRIFOLS S.A. has the market capitalization of 5.59 B, it has increased by 0.16% over the last week.
GRIFOLS S.A. dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS S.A. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 23.74 K employees. See our rating of the largest employees — is GRIFOLS S.A. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRIFOLS S.A. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRIFOLS S.A. stock shows the sell signal. See more of GRIFOLS S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GRIFOLS S.A. future price: according to them, GRF price has a max estimate of 27.80 EUR and a min estimate of 6.20 EUR. Read a more detailed GRIFOLS S.A. forecast: see what analysts think of GRIFOLS S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRIFOLS S.A. EBITDA is 1.30 B EUR, and current EBITDA margin is 17.90%. See more stats in GRIFOLS S.A. financial statements.